BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24966170)

  • 1. Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion.
    Elderbroom JL; Huang JJ; Gatza CE; Chen J; How T; Starr M; Nixon AB; Blobe GC
    Mol Biol Cell; 2014 Aug; 25(16):2320-32. PubMed ID: 24966170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.
    Gatza CE; Holtzhausen A; Kirkbride KC; Morton A; Gatza ML; Datto MB; Blobe GC
    Neoplasia; 2011 Aug; 13(8):758-70. PubMed ID: 21847367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TβRIII/β-arrestin2 regulates integrin α5β1 trafficking, function, and localization in epithelial cells.
    Mythreye K; Knelson EH; Gatza CE; Gatza ML; Blobe GC
    Oncogene; 2013 Mar; 32(11):1416-27. PubMed ID: 22562249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan sulfate modifications of betaglycan promote TIMP3-dependent ectodomain shedding to fine-tune TGF-β signaling.
    Choi AS; Jenkins-Lane LM; Barton W; Kumari A; Lancaster C; Raulerson C; Ji H; Altomare D; Starr MD; Whitaker R; Phaeton R; Arend R; Shtutman M; Nixon AB; Hempel N; Lee NY; Mythreye K
    bioRxiv; 2023 Aug; ():. PubMed ID: 37693479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A time- and matrix-dependent TGFBR3-JUND-KRT5 regulatory circuit in single breast epithelial cells and basal-like premalignancies.
    Wang CC; Bajikar SS; Jamal L; Atkins KA; Janes KA
    Nat Cell Biol; 2014 Apr; 16(4):345-56. PubMed ID: 24658685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The balance of cell surface and soluble type III TGF-β receptor regulates BMP signaling in normal and cancerous mammary epithelial cells.
    Gatza CE; Elderbroom JL; Oh SY; Starr MD; Nixon AB; Blobe GC
    Neoplasia; 2014 Jun; 16(6):489-500. PubMed ID: 25077702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.
    Tazat K; Hector-Greene M; Blobe GC; Henis YI
    Mol Biol Cell; 2015 Oct; 26(19):3535-45. PubMed ID: 26269580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII)/Betaglycan Modulates Canonical Wnt/β-Catenin Signaling.
    Jenkins LM; Singh P; Varadaraj A; Lee NY; Shah S; Flores HV; O'Connell K; Mythreye K
    J Biol Chem; 2016 Dec; 291(49):25716-25728. PubMed ID: 27784788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells revisited.
    Batlle E; Clevers H
    Nat Med; 2017 Oct; 23(10):1124-1134. PubMed ID: 28985214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Betaglycan sustains HGF/Met signaling in lung cancer and endothelial cells promoting cell migration and tumor growth.
    Cervantes-Villagrana RD; Mendoza V; Hinck CS; de la Fuente-León RL; Hinck AP; Reyes-Cruz G; Vázquez-Prado J; López-Casillas F
    Heliyon; 2024 May; 10(9):e30520. PubMed ID: 38756586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer.
    Choi AS; Jenkins-Lane LM; Barton W; Kumari A; Lancaster C; Raulerson C; Ji H; Altomare D; Starr MD; Whitaker R; Phaeton R; Arend R; Shtutman M; Nixon AB; Hempel N; Lee NY; Mythreye K
    Cell Commun Signal; 2024 Feb; 22(1):128. PubMed ID: 38360757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of novel serum biomarkers for gastric cancer in coastal populations using a protein microarray.
    Yi Y; Nan R; Lu J; Liang D; Zhao S; Wang X; Zhang H; Chen B; Chen J; Zheng Z; You T; Chen T; Chen X; Wang W; Lin L; Chen Y; Liu S; Huang Y; Yu Y; Lu M; Li P; Huang H; Zhou G; Lin X; Wu H; Shen X; Sun W
    Cancer Sci; 2023 Aug; 114(8):3396-3410. PubMed ID: 37290894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational modeling of TGF-β2:TβRI:TβRII receptor complex assembly as mediated by the TGF-β coreceptor betaglycan.
    Madamanchi A; Ingle M; Hinck AP; Umulis DM
    Biophys J; 2023 Apr; 122(7):1342-1354. PubMed ID: 36869592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colocalization with MMP-7 in the Distal Colon is Crucial for Syndecan-2 Shedding in Dextran Sulfate Sodium-Induced Colitis Mice.
    Hong H; Song HK; Jang B; Park E; Han DS; Kim SE; Oh ES
    J Inflamm Res; 2021; 14():4987-5000. PubMed ID: 34616168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canonical TGFβ Signaling and Its Contribution to Endometrial Cancer Development and Progression-Underestimated Target of Anticancer Strategies.
    Zakrzewski PK
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type III TGF-β Receptor Down-Regulation Promoted Tumor Progression via Complement Component C5a Induction in Hepatocellular Carcinoma.
    Yeung OWH; Qi X; Pang L; Liu H; Ng KTP; Liu J; Lo CM; Man K
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β superfamily co-receptors in cancer.
    Pawlak JB; Blobe GC
    Dev Dyn; 2022 Jan; 251(1):137-163. PubMed ID: 33797167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tumor-promoting role for soluble TβRIII in glioblastoma.
    Burghardt I; Schroeder JJ; Weiss T; Gramatzki D; Weller M
    Mol Cell Biochem; 2021 Aug; 476(8):2963-2973. PubMed ID: 33772427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels and tissue expression of soluble TGFβrIII receptor in women with early-stage breast cancer and in healthy women: a prospective observational study.
    Grgurevic L; Novak R; Trkulja V; Hrkac S; Salai G; Bilandzic J; Hamzic LF; Milas I; Vucemilo T; Balja MP; Bilic K
    J Transl Med; 2020 Dec; 18(1):478. PubMed ID: 33308241
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.